March is Multiple Myeloma Awareness Month. In this episode, we speak with TGen Associate Professor Jonathan Keats, Ph.D.

Dr. Keats’ revisits the COMPASS study from the Multiple Myeloma Research Foundationm a 12-year research project that examined the different forms of this blood cancer and revealed why some patients respond well to treatment while others face more aggressive disease. His work on the project led to the development of two advanced tests that can deliver results in days instead of weeks, helping doctors choose the most effective treatment for each patient.

These tests can also show when some patient may no longer need therapy, sparing many people from years of difficult and costly treatments. Listen as Dr. Keats shares why he believes the future is becoming much brighter for patients with multiple myeloma and other forms of cancer.